With earnings season in full swing, brokers have been running the rule over a large number of ASX 200 shares.
Two blue chip shares that have been named as post-results buys are listed below. Here's what you need to know about these shares:
Goodman Group (ASX: GMG)
The first blue chip ASX 200 share that has been tipped as a buy following its results release is Goodman.
It is leading industrial property company with a world class portfolio of assets that are in-demand with end users across the globe.
In response to its strong half-year results, Citi has retained its buy rating and $24.00 price target. The broker believes that strong demand will drive earnings growth for the foreseeable future. It commented:
GMG's 1H23 result highlighted the extent of tailwinds still existing for industrial property which make for a strong earnings growth outlook not just this year but into multiple years in the future. Higher than expected FUM, record development margins this period (~100%) and increased potential for rental reversion should support overall earnings growth into the future. Debt costs may be higher but lower gearing ensures limited impact to this. We believe GMG will continue to outperform given its high-quality exposure and strong earnings growth potential in an uncertain macro environment.
SEEK Limited (ASX: SEK)
Another blue chip ASX 200 share that has been named as a buy this week is Seek.
It is of course the job listings giant behind the eponymous Seek website, as well as several international equivalents.
Morgans was pleased with its performance in the first half and has recommended it as a post-results buy. Its analysts commented:
SEK's 1H23 result was ~2% ahead of Visible Alpha consensus at the topline (revenue of ~A$627m, +21% on pcp), with EBITDA of ~A$283m (+13% on pcp) in line and NPAT excluding significant items (A$135m, +9% on pcp) ~4% ahead. It was broadly a positive result, in our view, however job ad volume growth moderating in 2H23 (particularly ANZ), whilst not unexpected, looks to be a factor in guidance being set at the lower end of previously flagged ranges.
Morgans has retained its add rating with a trimmed price target of $28.40.
